248 related articles for article (PubMed ID: 20830649)
21. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
Denney DR; Lynch SG; Parmenter BA
J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653
[TBL] [Abstract][Full Text] [Related]
22. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
[TBL] [Abstract][Full Text] [Related]
23. Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Strober L; Chiaravalloti N; Moore N; DeLuca J
Mult Scler; 2014 Jan; 20(1):112-5. PubMed ID: 23635909
[TBL] [Abstract][Full Text] [Related]
24. Examining the relationship between cognition and driving performance in multiple sclerosis.
Schultheis MT; Weisser V; Ang J; Elovic E; Nead R; Sestito N; Fleksher C; Millis SR
Arch Phys Med Rehabil; 2010 Mar; 91(3):465-73. PubMed ID: 20298841
[TBL] [Abstract][Full Text] [Related]
25. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up.
Amato MP; Goretti B; Ghezzi A; Lori S; Zipoli V; Moiola L; Falautano M; De Caro MF; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Roscio M; Martinelli V; Comi G; Portaccio E; Trojano M;
Neurology; 2010 Sep; 75(13):1134-40. PubMed ID: 20876467
[TBL] [Abstract][Full Text] [Related]
26. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis.
Christodoulou C; Melville P; Scherl WF; Morgan T; MacAllister WS; Canfora DM; Berry SA; Krupp LB
J Int Neuropsychol Soc; 2005 Sep; 11(5):614-9. PubMed ID: 16212689
[TBL] [Abstract][Full Text] [Related]
27. Influence of recruitment and participation bias in neuropsychological research among MS patients.
Duquin JA; Parmenter BA; Benedict RH
J Int Neuropsychol Soc; 2008 May; 14(3):494-8. PubMed ID: 18419848
[TBL] [Abstract][Full Text] [Related]
28. Minimal neuropsychological assessment of MS patients: a consensus approach.
Benedict RH; Fischer JS; Archibald CJ; Arnett PA; Beatty WW; Bobholz J; Chelune GJ; Fisk JD; Langdon DW; Caruso L; Foley F; LaRocca NG; Vowels L; Weinstein A; DeLuca J; Rao SM; Munschauer F
Clin Neuropsychol; 2002 Aug; 16(3):381-97. PubMed ID: 12607150
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.
Morrow SA; O'Connor PW; Polman CH; Goodman AD; Kappos L; Lublin FD; Rudick RA; Jurgensen S; Paes D; Forrestal F; Benedict RH
Mult Scler; 2010 Nov; 16(11):1385-92. PubMed ID: 20739335
[TBL] [Abstract][Full Text] [Related]
30. Relationship between global cognitive decline and depressive symptoms in multiple sclerosis.
Barwick FH; Arnett PA
Clin Neuropsychol; 2011 Feb; 25(2):193-209. PubMed ID: 21246447
[TBL] [Abstract][Full Text] [Related]
31. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
[TBL] [Abstract][Full Text] [Related]
32. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS.
Carone DA; Benedict RH; Munschauer FE; Fishman I; Weinstock-Guttman B
J Int Neuropsychol Soc; 2005 Sep; 11(5):574-83. PubMed ID: 16212684
[TBL] [Abstract][Full Text] [Related]
33. Cognitive impairment and decline in different MS subtypes.
Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Polman CH
J Neurol Sci; 2006 Jun; 245(1-2):187-94. PubMed ID: 16643951
[TBL] [Abstract][Full Text] [Related]
34. Memory decline evolves independently of disease activity in MS.
Duque B; Sepulcre J; Bejarano B; Samaranch L; Pastor P; Villoslada P
Mult Scler; 2008 Aug; 14(7):947-53. PubMed ID: 18573817
[TBL] [Abstract][Full Text] [Related]
35. Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Eshaghi A; Riyahi-Alam S; Roostaei T; Haeri G; Aghsaei A; Aidi MR; Pouretemad HR; Zarei M; Farhang S; Saeedi R; Nazeri A; Ganjgahi H; Etesam F; Azimi AR; Benedict RH; Sahraian MA
Clin Neuropsychol; 2012; 26(6):975-84. PubMed ID: 22681459
[TBL] [Abstract][Full Text] [Related]
36. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L
Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
[TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
Rogers JM; Panegyres PK
J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
[TBL] [Abstract][Full Text] [Related]
38. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
Dusankova JB; Kalincik T; Havrdova E; Benedict RH
Clin Neuropsychol; 2012; 26(7):1186-200. PubMed ID: 23034066
[TBL] [Abstract][Full Text] [Related]
39. Cognitive impairment in different MS subtypes and clinically isolated syndromes.
Potagas C; Giogkaraki E; Koutsis G; Mandellos D; Tsirempolou E; Sfagos C; Vassilopoulos D
J Neurol Sci; 2008 Apr; 267(1-2):100-6. PubMed ID: 17997417
[TBL] [Abstract][Full Text] [Related]
40. Perceived cognitive difficulties and cognitive test performance as predictors of employment outcomes in people with multiple sclerosis.
Honan CA; Brown RF; Batchelor J
J Int Neuropsychol Soc; 2015 Feb; 21(2):156-68. PubMed ID: 25727930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
